Capital City Trust Co. FL Sells 804 Shares of McKesson Corporation (MCK)
Capital City Trust Co. FL reduced its stake in shares of McKesson Corporation (NYSE:MCK) by 5.5% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 13,834 shares of the company’s stock after selling 804 shares during the period. Capital City Trust Co. FL’s holdings in McKesson Corporation were worth $2,276,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of the stock. Macquarie Group Ltd. boosted its position in McKesson Corporation by 1.9% in the fourth quarter. Macquarie Group Ltd. now owns 49,668 shares of the company’s stock valued at $6,976,000 after buying an additional 917 shares during the last quarter. National Pension Service boosted its position in McKesson Corporation by 2.8% in the first quarter. National Pension Service now owns 171,198 shares of the company’s stock valued at $25,591,000 after buying an additional 4,673 shares during the last quarter. Regentatlantic Capital LLC boosted its position in McKesson Corporation by 9.9% in the first quarter. Regentatlantic Capital LLC now owns 3,702 shares of the company’s stock valued at $549,000 after buying an additional 334 shares during the last quarter. Orrstown Financial Services Inc. boosted its position in McKesson Corporation by 16.3% in the first quarter. Orrstown Financial Services Inc. now owns 715 shares of the company’s stock valued at $106,000 after buying an additional 100 shares during the last quarter. Finally, TNB Financial acquired a new position in McKesson Corporation during the first quarter valued at about $207,000. Hedge funds and other institutional investors own 89.10% of the company’s stock.
Shares of McKesson Corporation (NYSE MCK) opened at 151.07 on Friday. McKesson Corporation has a 1-year low of $114.53 and a 1-year high of $197.08. The stock has a market cap of $31.76 billion, a price-to-earnings ratio of 6.85 and a beta of 1.13. The company has a 50-day moving average price of $163.30 and a 200-day moving average price of $151.95.
McKesson Corporation (NYSE:MCK) last posted its quarterly earnings data on Thursday, July 27th. The company reported $2.46 EPS for the quarter, missing the Zacks’ consensus estimate of $2.81 by $0.35. McKesson Corporation had a net margin of 2.42% and a return on equity of 25.76%. The company had revenue of $51.05 billion for the quarter, compared to analyst estimates of $51.22 billion. During the same quarter in the prior year, the business earned $3.50 EPS. McKesson Corporation’s revenue was up 2.7% compared to the same quarter last year. On average, equities analysts expect that McKesson Corporation will post $12.09 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Friday, September 1st will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Wednesday, August 30th. This is a positive change from McKesson Corporation’s previous quarterly dividend of $0.28. McKesson Corporation’s dividend payout ratio (DPR) is currently 5.00%.
Several equities analysts have issued reports on the company. Vetr upgraded McKesson Corporation from a “buy” rating to a “strong-buy” rating and set a $181.27 target price on the stock in a research report on Monday, June 19th. Jefferies Group LLC assumed coverage on McKesson Corporation in a research report on Wednesday, May 17th. They set a “hold” rating and a $153.00 target price on the stock. Evercore ISI reiterated an “outperform” rating and set a $166.00 target price on shares of McKesson Corporation in a research report on Monday, April 17th. UBS Group AG reiterated a “neutral” rating and set a $166.00 target price (up previously from $156.00) on shares of McKesson Corporation in a research report on Monday, June 26th. Finally, TheStreet upgraded McKesson Corporation from a “c+” rating to a “b” rating in a research report on Thursday, May 25th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $171.21.
In other McKesson Corporation news, Director Marie L/Ca Knowles sold 1,083 shares of McKesson Corporation stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $162.55, for a total value of $176,041.65. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Erin M. Lampert sold 404 shares of McKesson Corporation stock in a transaction that occurred on Tuesday, May 30th. The stock was sold at an average price of $160.53, for a total transaction of $64,854.12. Following the completion of the transaction, the senior vice president now owns 2,003 shares in the company, valued at approximately $321,541.59. The disclosure for this sale can be found here. Insiders have sold 60,231 shares of company stock worth $9,830,297 in the last quarter. Company insiders own 1.20% of the company’s stock.
McKesson Corporation Company Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK).
Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.